NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01872962,Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT01872962,,UNKNOWN,"The purpose of this study is to compare induction chemotherapy (gemcitabine+cisplatin) plus concurrent chemoradiotherapy (CCRT) with CCRT alone in patients with locoregionally advanced nasopharyngeal carcinoma(NPC), in order to confirm the value of induction chemotherapy in NPC patients.",NO,Nasopharyngeal Carcinoma,DRUG: gemcitabine and cisplatin (Induction chemotherapy)|RADIATION: IMRT and concurrent cisplatin,"Failure-free survival, Failure-free survival rate is calculated from the date of randomization to the date of treatment failure or death from any cause, whichever is first., 3-year","Overall survival, Overall survival is calculated from randomization to death from any cause., 3-year|Locoregional failure-free survival, Locoregional failure-free survival is calculated from randomization to the first locoregional failure., 3-year|Distant failure-free survival, Distant failure-free survival is calculated from randomization to the first remote failure., 3-year|Number of participants with adverse events, Incidence of acute and late toxicity, up to 3 years",,Sun Yat-sen University,"Fudan University|West China Hospital|Tongji Hospital|Peking University|Zhejiang Cancer Hospital|First People's Hospital of Foshan|Cancer Hospital of Guangxi Medical University|Jiangxi Provincial Cancer Hospital|Xijing hospital of The fourth military medical university|Cancer Hospital of Guizhou Province|Affiliated Cancer Hospital of Shantou University Medical College|Fifth Affiliated Hospital, Sun Yat-Sen University|Wuhan Union Hospital, China",ALL,"ADULT, OLDER_ADULT",PHASE3,480,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,B2013-022-01,2013-11,2018-11,2020-11,2013-06-07,,2018-04-24,"Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China",
